Publikationen in Zusammenarbeit mit Forschern von Institut d'Investigacions Biomèdiques August Pi i Sunyer (27)

2024

  1. Coping behaviors to reduce anxiety and depressive symptoms: A prospective repeated assessment study

    Spanish Journal of Psychiatry and Mental Health

  2. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

2023

  1. Do the negative symptoms of schizophrenia reflect reduced responsiveness to reward? Examination using a reward prediction error (RPE) task

    Psychological Medicine, Vol. 20

  2. Improved estimation of the risk of manic relapse by combining clinical and brain scan data

    Revista de Psiquiatria y Salud Mental

  3. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Negative schizophrenic symptoms as prefrontal cortex dysfunction: Examination using a task measuring goal neglect

    NeuroImage: Clinical, Vol. 35

  2. Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders

    Journal of Clinical Medicine, Vol. 11, Núm. 22

  3. The network structure of cognitive deficits in first episode psychosis patients

    Schizophrenia Research, Vol. 244, pp. 46-54

  4. Validity of the Functioning Assessment Short Tests (FAST), in patients with schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 3, pp. 157-166

2021

  1. Altered brain responses to specific negative emotions in schizophrenia

    NeuroImage: Clinical, Vol. 32

  2. Coping strategies patterns to buffer the psychological impact of the State of Emergency in Spain during the COVID-19 pandemic’s early months

    Scientific Reports, Vol. 11, Núm. 1

  3. Difficulties in delivery and depressive symptomatology in schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 1, pp. 66-68

  4. Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms

    Frontiers in Psychiatry, Vol. 12

  5. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2019

  1. Early detection of subtle motor dysfunction in cognitively normal subjects with amyloid-β positivity

    Cortex, Vol. 121, pp. 117-124

  2. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

  3. Influence of secondary sources in the Brief Negative Symptom Scale

    Schizophrenia Research

2018

  1. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711

  2. Inverse association between negative symptoms and body mass index in chronic schizophrenia

    Schizophrenia Research, Vol. 192, pp. 69-74